What happens when medication is discontinued: Studies show most people regain some or all weight lost when stopping therapy, suggesting a life-long reliance to maintain results
Semaglutide injection focuses primarily on GLP-1 pathways, regulating appetite and slowing digestion Tirzepatide targets both GLP-1 and GIP receptors, offering a broader metabolic effect Tirzepatide may produce more pronounced weight loss in some individuals Semaglutide is often used as a starting point or for steady, controlled progress The choice between the two depends on individual goals, metabolic profile, and response to treatment
Annual Review of Pharmacology and Toxicology
The oral GLP-1 space is advancing too, with orforglipron versus tirzepatide representing a potential future where daily pills replace weekly injections
doi: 10.1007/s12325-022-02153-x
Michigan Blue Cross Blue Shield expands access to prescription refills MICHIGAN (WPBN/WGTU) -- If you are worried about getting your regular prescriptions during the epidemic, here is some good news